These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30147308)

  • 1. Burden of disease associated with a COPD eosinophilic phenotype.
    Ortega H; Llanos JP; Lafeuille MH; Germain G; Duh MS; Bell CF; Sama SR; Hahn B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2425-2433. PubMed ID: 30147308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort.
    Trudo F; Kallenbach L; Vasey J; Chung Y; Wilk A; Slipski L; O'Brien D; Strange C
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2625-2637. PubMed ID: 32063703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical burden of illness among patients with severe eosinophilic COPD.
    Müllerová H; Meeraus WH; Galkin DV; Albers FC; Landis SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():741-755. PubMed ID: 31114180
    [No Abstract]   [Full Text] [Related]  

  • 4. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.
    Müllerová H; Hahn B; Simard EP; Mu G; Hatipoğlu U
    Int J Chron Obstruct Pulmon Dis; 2019; 14():683-692. PubMed ID: 30962682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada.
    Poder TG; Carrier N; Bélanger M; Couillard S; Courteau J; Larivée P; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3065-3076. PubMed ID: 30349220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
    Benson VS; Pascoe KC; Siddall J; Small M; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.
    Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
    COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain.
    Alcázar-Navarrete B; García-Rio F; Sánchez G; Mariscal E; García A; Cuesta M; Uría E; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2149-2161. PubMed ID: 34321874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD exacerbation frequency and its association with health care resource utilization and costs.
    Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
    Yun JH; Lamb A; Chase R; Singh D; Parker MM; Saferali A; Vestbo J; Tal-Singer R; Castaldi PJ; Silverman EK; Hersh CP;
    J Allergy Clin Immunol; 2018 Jun; 141(6):2037-2047.e10. PubMed ID: 29709670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization.
    Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2409-2421. PubMed ID: 31749614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO.
    Pavord ID; Chapman KR; Bafadhel M; Sciurba FC; Bradford ES; Schweiker Harris S; Mayer B; Rubin DB; Yancey SW; Paggiaro P
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1755-1770. PubMed ID: 34163157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research Datalink.
    Landis SH; Suruki R; Hilton E; Compton C; Galwey NW
    COPD; 2017 Aug; 14(4):382-388. PubMed ID: 28569614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD.
    Nakamura S; Wakahara K; Majima S; Yokoi E; Fukutani E; Otsuki R; Iwano S; Chen-Yoshikawa TF; Kinoshita F; Abe T; Sashio T; Kimura T; Izuhara K; Hashimoto N; Ishii M; Hasegawa Y
    BMC Pulm Med; 2024 Oct; 24(1):510. PubMed ID: 39396940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.